315 related articles for article (PubMed ID: 25445833)
21. ATR-FTIR spectroscopic imaging to study the drying and dissolution of pharmaceutical polymer-based films.
Hifumi H; Ewing AV; Kazarian SG
Int J Pharm; 2016 Dec; 515(1-2):57-68. PubMed ID: 27720876
[TBL] [Abstract][Full Text] [Related]
22. Impact of polymeric excipient on cocrystal formation via hot-melt extrusion and subsequent downstream processing.
Karimi-Jafari M; Ziaee A; Iqbal J; O'Reilly E; Croker D; Walker G
Int J Pharm; 2019 Jul; 566():745-755. PubMed ID: 31212053
[TBL] [Abstract][Full Text] [Related]
23. An investigation into the use of polymer blends to improve the printability of and regulate drug release from pharmaceutical solid dispersions prepared via fused deposition modeling (FDM) 3D printing.
Alhijjaj M; Belton P; Qi S
Eur J Pharm Biopharm; 2016 Nov; 108():111-125. PubMed ID: 27594210
[TBL] [Abstract][Full Text] [Related]
24. Probing the Molecular-Level Interactions in an Active Pharmaceutical Ingredient (API) - Polymer Dispersion and the Resulting Impact on Drug Product Formulation.
Yang F; Su Y; Small J; Huang C; Martin GE; Farrington AM; DiNunzio J; Brown CD
Pharm Res; 2020 May; 37(6):94. PubMed ID: 32405662
[TBL] [Abstract][Full Text] [Related]
25. Development of Amorphous Solid Dispersion Sustained-Release Formulations with Polymer Composite Matrix-Regulated Stable Release Plateaus.
Chen L; Hu E; Shen P; Qian S; Heng W; Zhang J; Gao Y; Wei Y
Pharm Res; 2024 Jun; 41(6):1233-1245. PubMed ID: 38744732
[TBL] [Abstract][Full Text] [Related]
26. In Situ Salt Formation during Melt Extrusion for Improved Chemical Stability and Dissolution Performance of a Meloxicam-Copovidone Amorphous Solid Dispersion.
Haser A; Cao T; Lubach JW; Zhang F
Mol Pharm; 2018 Mar; 15(3):1226-1237. PubMed ID: 29412681
[TBL] [Abstract][Full Text] [Related]
27. Continuous production of itraconazole-based solid dispersions by hot melt extrusion: Preformulation, optimization and design space determination.
Thiry J; Lebrun P; Vinassa C; Adam M; Netchacovitch L; Ziemons E; Hubert P; Krier F; Evrard B
Int J Pharm; 2016 Dec; 515(1-2):114-124. PubMed ID: 27720874
[TBL] [Abstract][Full Text] [Related]
28. Engineering of pharmaceutical cocrystals in an excipient matrix: Spray drying versus hot melt extrusion.
Walsh D; Serrano DR; Worku ZA; Madi AM; O'Connell P; Twamley B; Healy AM
Int J Pharm; 2018 Nov; 551(1-2):241-256. PubMed ID: 30223079
[TBL] [Abstract][Full Text] [Related]
29. Application of carrier and plasticizer to improve the dissolution and bioavailability of poorly water-soluble baicalein by hot melt extrusion.
Zhang Y; Luo R; Chen Y; Ke X; Hu D; Han M
AAPS PharmSciTech; 2014 Jun; 15(3):560-8. PubMed ID: 24570374
[TBL] [Abstract][Full Text] [Related]
30. Enhanced Dissolution of a Porous Carrier-Containing Ternary Amorphous Solid Dispersion System Prepared by a Hot Melt Method.
Hanada M; Jermain SV; Williams RO
J Pharm Sci; 2018 Jan; 107(1):362-371. PubMed ID: 28989021
[TBL] [Abstract][Full Text] [Related]
31. Implementation of transmission NIR as a PAT tool for monitoring drug transformation during HME processing.
Islam MT; Scoutaris N; Maniruzzaman M; Moradiya HG; Halsey SA; Bradley MS; Chowdhry BZ; Snowden MJ; Douroumis D
Eur J Pharm Biopharm; 2015 Oct; 96():106-16. PubMed ID: 26209124
[TBL] [Abstract][Full Text] [Related]
32. Soluplus®/TPGS-based solid dispersions prepared by hot-melt extrusion equipped with twin-screw systems for enhancing oral bioavailability of valsartan.
Lee JY; Kang WS; Piao J; Yoon IS; Kim DD; Cho HJ
Drug Des Devel Ther; 2015; 9():2745-56. PubMed ID: 26045660
[TBL] [Abstract][Full Text] [Related]
33. Influence of lidocaine forms (salt vs. freebase) on properties of drug-eudragit® L100-55 extrudates prepared by reactive melt extrusion.
Liu X; Ma X; Kun E; Guo X; Yu Z; Zhang F
Int J Pharm; 2018 Aug; 547(1-2):291-302. PubMed ID: 29883791
[TBL] [Abstract][Full Text] [Related]
34. Synergistic Effect of Polyvinyl Alcohol and Copovidone in Itraconazole Amorphous Solid Dispersions.
Wlodarski K; Zhang F; Liu T; Sawicki W; Kipping T
Pharm Res; 2018 Jan; 35(1):16. PubMed ID: 29305665
[TBL] [Abstract][Full Text] [Related]
35. Formulation development and investigation of ibuprofen controlled release tablets with hydrophilic polymers and the effect of co-excipients on drug release patterns.
Jan SU; Khan GM; Hussain I
Pak J Pharm Sci; 2012 Oct; 25(4):751-6. PubMed ID: 23009990
[TBL] [Abstract][Full Text] [Related]
36. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension.
Zhang K; Yu H; Luo Q; Yang S; Lin X; Zhang Y; Tian B; Tang X
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1285-92. PubMed ID: 23562534
[TBL] [Abstract][Full Text] [Related]
37. Influence of Plasdone
Butreddy A; Sarabu S; Bandari S; Batra A; Lawal K; Chen NN; Bi V; Durig T; Repka MA
AAPS PharmSciTech; 2021 Jun; 22(5):196. PubMed ID: 34184149
[TBL] [Abstract][Full Text] [Related]
38. Effect of composition in the development of carbamazepine hot-melt extruded solid dispersions by application of mixture experimental design.
Djuris J; Ioannis N; Ibric S; Djuric Z; Kachrimanis K
J Pharm Pharmacol; 2014 Feb; 66(2):232-43. PubMed ID: 24350884
[TBL] [Abstract][Full Text] [Related]
39. Investigation of a suitable in vitro dissolution test for itraconazole-based solid dispersions.
Thiry J; Broze G; Pestieau A; Tatton AS; Baumans F; Damblon C; Krier F; Evrard B
Eur J Pharm Sci; 2016 Mar; 85():94-105. PubMed ID: 26850682
[TBL] [Abstract][Full Text] [Related]
40. Solid-state characterization of Felodipine-Soluplus amorphous solid dispersions.
Lu J; Cuellar K; Hammer NI; Jo S; Gryczke A; Kolter K; Langley N; Repka MA
Drug Dev Ind Pharm; 2016; 42(3):485-96. PubMed ID: 26530290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
